Submitted:
08 January 2024
Posted:
10 January 2024
You are already at the latest version
Abstract
Keywords:
Introduction:
Materials and Methods


Results

Discussion
Current and Future Developments
Conclusion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Akter, S., et al. (2013). "Antidiarrhoeal activity of rind of Punica granatum." International Current Pharmaceutical Journal 2(5): 101-104.
- Ali, S. H., et al. (2020). "INHIBITORY ACTIVITY OF AQUEOUS EXTRACT OF POMEGRANATE PEEL AND CAROB AGAINST BACTERIA ISOLATED FROM DIARRHEAL PATIENT IN KIRKUK HOSPITAL." Plant Archives 20(1): 2467-2470.
- Asif, H., et al. (2010). "Herbal treatment of secretory diarrhea." International Journal of Phytomedicine 2(4).
- Cho, Y.-i. and K.-J. Yoon "An overview of calf diarrhea-infectious etiology, diagnosis, and intervention." Journal of veterinary science 15(1): 1-17.
- Hollebeeck, S., et al. (2012). "The use of pomegranate (Punica granatum l.) phenolic compounds as potential natural prevention against IBDs." Inflamm. Bowel Dis. Adv. Pathog. Manag. Intech-Publ. Belg: 275-300.
- Qnais, E., et al. (2007). "Antidiarrheal Activity of the Aqueous extract of Punica granatum.(Pomegranate) peels." Pharmaceutical Biology 45(9): 715-720.
- Saeed, M., et al. (2018). "The promising pharmacological effects and therapeutic/medicinal applications of punica granatum L.(Pomegranate) as a functional food in humans and animals." Recent Patents on Inflammation & Allergy Drug Discovery 12(1): 24-38.
- Seeram, N. P., et al. (2005). "In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice." The Journal of nutritional biochemistry 16(6): 360-367. [CrossRef]
- Vroegrijk, I. O., et al. (2011). "Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice." Food and Chemical Toxicology 49(6): 1426-1430. [CrossRef]
- Zhu, H., et al. (2020). "Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1." Experimental and therapeutic medicine 20(6): 1-1.

| Sr.# | Properties | Case (A) | Case (B) | Case(C) |
|---|---|---|---|---|
| 01. | Animal | Desi cow | Buffalo Neeli Ravi | Desi & Sahiwal Crossed |
| 02. | Gender | Female | Female | Female |
| 03. | Age | 5 Years | 3 Months | 4 Years |
| 04. | Color | Dark Brown | Black | Red |
| 05. | Disease | Diarrhea | Diarrhea | Diarrhea |
| 06. | Dose Administration | Orally | Orally | Orally |
| 07. | Treatment | |||
| I. | 1st Dose Date: June 11, 2022 Time: 11:20 am |
8 grams of Pomegranate Peel Powder mixed with 1 litre of water | 2 grams of Pomegranate Peel Powder mixed with 250 ml water | 8 grams of Pomegranate Peel Powder mixed with 1 litre of water |
| II. | 2nd Dose Date: June 11, 2022 Time: 07:20 pm |
8 grams of Pomegranate Peel Powder mixed with 1 litre of water | 2 grams of Pomegranate Peel Powder mixed with 250 ml water | 8 grams of Pomegranate Peel Powder mixed with 1 litre of water |
| III. | 3rd Dose Date: June 12, 2022 Time: 03:20 am |
8 grams of Pomegranate Peel Powder mixed with 1,000 ml. of water | 2 grams of Pomegranate Peel Powder mixed with 250 ml water | 8 grams of Pomegranate Peel Powder mixed with 1,000 ml. of water |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).